Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LQDA | LIQUIDIA CORP | $61.77 | $18.10 | 241.22% | 257.38x | 18.63x | 18.87x | 50.59x | 1.22x | $41.15M | 0.76% | $108.58M | 1.23 | $5.45B | 101.77 | ||
| SLNO | SOLENO THERAPEUTICS INC | $53.01 | $59.01 | -10.17% | 28.65x | 13.16x | 9.69x | 5.57x | 0.36x | $105.42M | 3.82% | $495.80M | 9.52 | $2.68B | 24.95 | ||
| CORT | CORCEPT THERAPEUTICS INC | $59.06 | $18.66 | 216.52% | 128.39x | 112.80x | 8.02x | 9.94x | 1.21x | $119.79M | 1.94% | $637.99M | 6.11 | $6.24B | -908.98 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $298.48 | $93.29 | 219.96% | 68.46x | 40.47x | 9.25x | 37.06x | 1.41x | $641.34M | 1.62% | $1.08B | 8.09 | $41.11B | 44.47 | ||
| HALO | HALOZYME THERAPEUTICS INC | $68.98 | $69.82 | -1.21% | 23.30x | 8.33x | 5.40x | 37.25x | 0.42x | $667.65M | 8.19% | $219.64M | 1.86 | $10.01B | 16.05 | ||
| KRYS | KRYSTAL BIOTECH INC | $302.05 | $94.72 | 218.89% | 38.97x | 37.36x | 21.20x | 6.97x | 1.85x | $237.38M | 2.68% | $1.28B | 43.59 | $8.41B | 39.32 | ||
| ADMA | ADMA BIOLOGICS INC | $8.56 | $10.38 | -17.55% | 12.41x | 8.62x | 3.96x | 5.08x | 0.42x | $107.90M | 5.34% | $390.33M | 1.65 | $2.04B | 9.23 | ||
| VCEL | VERICEL CORP | $35.40 | $9.05 | 291.30% | 82.33x | 73.43x | 6.15x | 5.07x | 1.73x | $47.49M | 2.64% | $356.23M | 7.02 | $1.79B | 44.36 | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $6.23 | $2.80 | 122.78% | 89.00x | 52.13x | 3.37x | 82.67x | 0.85x | $47.52M | 4.48% | $13.01M | 0.08 | $1.22B | 22.88 | ||
| RPRX | ROYALTY PHARMA PLC | $53.06 | $39.49 | 34.36% | 27.78x | 9.95x | 9.50x | 3.07x | 0.60x | $2.34B | 10.10% | $9.94B | 22.75 | $38.92B | 33.46 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $50.20 | $40.43 | 24.16% | 35.86x | 12.64x | 2.98x | 1.56x | 0.50x | $767.06M | 7.94% | $6.21B | 32.27 | $8.06B | 16.71 | ||
| OMER | OMEROS CORP | $12.38 | $15.37 | -19.47% | 9.52x | -32.51x | 89.71x | -14.15x | 0.48x | -$94.78M | -10.65% | -$63.33M | -0.88 | $1.20B | 13.32 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $10.24 | $16.10 | -36.41% | 5.00x | 21.79x | 4.89x | 2.94x | 0.63x | $56.42M | 9.43% | $205.80M | 3.52 | $510.89M | 3.53 | ||
| ASND | ASCENDIS PHARMA A | $241.34 | $82.95 | 190.94% | 25.58x | 19.43x | 14.72x | 26.11x | 2.38x | $52.94M | 0.35% | $574.09M | 9.24 | $15.37B | 164.83 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $239.01 | $48.27 | 395.16% | 508.53x | 9.26x | 3.33x | 3.31x | 1.74x | $1.30B | 8.77% | $4.53B | 73.22 | $18.55B | 27.49 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $54.28 | $15.74 | 244.86% | 55.39x | 49.21x | 5.51x | 6.89x | 1.70x | $164.23M | 3.95% | $605.69M | 7.92 | $4.00B | 35.84 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $217.75 | $94.75 | 129.81% | 27.56x | 24.16x | 15.77x | 4.38x | 1.35x | $122.22M | 2.82% | $997.32M | 50.16 | $4.70B | 20.84 | ||
| SPRO | SPERO THERAPEUTICS INC | $2.63 | $5.68 | -53.69% | 9.74x | 3.85x | 2.46x | 2.88x | 0.20x | $7.24M | 4.79% | $52.93M | 0.92 | $98.63M | 6.36 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $31.38 | $35.50 | -11.62% | 12.40x | 8.55x | 2.02x | 2.00x | 0.47x | $341.79M | 18.84% | $910.35M | 15.75 | $1.39B | 5.85 | ||
| TECH | BIO-TECHNE CORP | $46.70 | $15.24 | 206.51% | 65.77x | 23.75x | 6.03x | 3.51x | 1.35x | $269.60M | 3.69% | $2.09B | 13.34 | $7.39B | 28.88 | ||
| TGTX | TG THERAPEUTICS INC | $39.76 | $18.44 | 115.64% | 12.35x | 26.49x | 8.20x | 10.44x | 8.08x | -$14.19M | -0.25% | $583.13M | 4.04 | $6.39B | 42.63 | ||
| EXEL | EXELIXIS INC | $49.90 | $30.54 | 63.38% | 15.99x | 15.15x | 5.43x | 6.48x | 1.16x | $917.69M | 7.12% | $1.94B | 7.49 | $12.49B | 11.82 | ||
| UTHR | UNITED THERAPEUTICS CORP | $563.93 | $244.92 | 130.25% | 19.26x | 19.40x | 7.74x | 4.06x | 2.04x | $1.02B | 4.15% | $5.90B | 135.66 | $22.66B | 13.22 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.75 | $2.44 | 53.98% | 15.63x | 15.85x | 2.30x | 3.63x | 1.05x | $4.11M | 1.36% | $82.33M | 1.03 | $234.69M | 11.05 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $31.25 | $14.75 | 111.84% | 17.27x | 16.24x | 6.40x | 3.78x | 1.96x | $208.13M | 5.45% | $1.01B | 8.28 | $3.07B | 9.17 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $430.44 | $168.07 | 156.11% | 25.31x | 22.00x | 8.95x | 5.64x | 1.81x | $3.71B | 3.39% | $19.36B | 76.20 | $105.74B | 19.61 | ||
| VCYT | VERACYTE INC | $45.19 | $12.22 | 269.88% | 40.71x | 40.15x | 6.63x | 2.68x | 2.34x | $155.34M | 4.32% | $1.34B | 16.90 | $3.38B | 29.38 | ||
| MDXG | MIMEDX GROUP INC | $3.79 | $1.55 | 145.12% | 18.05x | -53.08x | 1.44x | 2.32x | 2.80x | $69.36M | 12.32% | $242.94M | 1.64 | $422.33M | 7.75 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $2.01 | $1.72 | 16.56% | 10.58x | 9.25x | 2.10x | 2.41x | 0.91x | $13.00M | 8.11% | $67.23M | 0.84 | $128.72M | 5.77 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $649.76 | $438.53 | 48.17% | 15.27x | 13.74x | 4.53x | 2.17x | 1.00x | $4.11B | 6.09% | $31.42B | 302.15 | $67.86B | 11.81 | ||
| INCY | INCYTE CORP | $97.08 | $65.49 | 48.23% | 13.32x | 12.33x | 3.61x | 3.45x | 1.18x | $1.45B | 7.50% | $5.62B | 28.21 | $15.97B | 8.53 | ||
| SRPT | SAREPTA THERAPEUTICS INC | $17.12 | $4.56 | 275.82% | 28.53x | 4.91x | 0.82x | 1.20x | 4.00x | $109.24M | 6.07% | $1.51B | 14.34 | $2.38B | 28.76 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.